![Moses Makunje](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 325 695 $ al 31/05/2026
Moses Makunje is currently VP-Finance & Principal Accounting Officer at Nuvation Bio, Inc. since 2020.
Formerly, Mr. Makunje was Controller at Adverum Biotechnologies, Inc. from 2017 to 2019 and Controller at Maze Therapeutics, Inc. from 2019 to 2020.
Mr. Makunje completed undergraduate and MBA degrees at Golden Gate University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 27/02/2026 | 68.137 ( 0,02 % ) | 325 695 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| NUVATION BIO INC. | Comptroller/Controller/Auditor | 27/11/2023 |
| Empresas | Cargo | Fin |
|---|---|---|
Maze Therapeutics, Inc.
 Maze Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicine for cardiovascular, renal and metabolic diseases | Comptroller/Controller/Auditor | 01/07/2020 |
| ADVERUM BIOTECHNOLOGIES, INC. | Comptroller/Controller/Auditor | 01/03/2019 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Golden Gate University
 Golden Gate University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adverum Biotechnologies, Inc.
 Adverum Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells novel gene therapies | Health Technology |
Maze Therapeutics, Inc.
Maze Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicine for cardiovascular, renal and metabolic diseases | Health Technology |
Nuvation Bio, Inc.
 Nuvation Bio, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops oncology related novel therapeutic candidates | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
Elige MarketScreener 
